Cellular and Molecular Gastroenterology and Hepatology ( IF 7.1 ) Pub Date : 2023-10-20 , DOI: 10.1016/j.jcmgh.2023.10.004
Qin Zhu 1 , Yu Hu 1 , Wei Jiang 1 , Zheng-Lin Ou 1 , Yuan-Bing Yao 1 , Hong-Yan Zai 1
![]() |
Background & Aims
Circ-CCT2 (hsa_circ_0000418) is a novel circular RNA that stems from the CCT2 gene. However, the expression of circ-CCT2 and its roles in hepatoblastoma are unknown. Our study aims to study the circ-CCT2 roles in hepatoblastoma development.
Methods
Hepatoblastoma specimens were collected for examining the expression of circ-CCT2, TAF15, and PTBP1. CCK-8 and colony formation assays were applied for cell proliferation analysis. Migratory and invasive capacities were evaluated through wound healing and Transwell assays. The interaction between circ-CCT2, TAF15, and PTBP1 was validated by fluorescence in situ hybridization, RNA pull-down, and RNA immunoprecipitation. SKL2001 was used as an agonist of the Wnt/β-catenin pathway. A subcutaneous mouse model of hepatoblastoma was established for examining the function of circ-CCT2 in hepatoblastoma in vivo.
Results
Circ-CCT2 was significantly up-regulated in hepatoblastoma. Overexpression of circ-CCT2 activated Wnt/β-catenin signaling and promoted hepatoblastoma progression, whereas knockdown of circ-CCT2 exerted opposite effects. Moreover, both TAF15 and PTBP1 were up-regulated in hepatoblastoma tissues and cells. TAF15 was positively correlated with the expression of circ-CCT2 and PTBP1 in hepatoblastoma. Furthermore, circ-CCT2 recruited and up-regulated TAF15 protein to stabilize PTBP1 mRNA and trigger Wnt/β-catenin signaling in hepatoblastoma. Overexpression of TAF15 or PTBP1 reversed knockdown of circ-CCT2–mediated suppression of hepatoblastoma progression. SKL2001-mediated activation of Wnt/β-catenin signaling reversed the anti-tumor effects of silencing of circ-CCT2, TAF15, or PTBP1.
Conclusions
Circ-CCT2 stabilizes PTBP1 mRNA and activates Wnt/β-catenin signaling through recruiting and up-regulating TAF15 protein, thus promoting hepatoblastoma progression. Our findings deepen the understanding of hepatoblastoma pathogenesis and suggest potential therapeutic targets.
中文翻译:

Circ-CCT2 激活 Wnt/β-catenin 信号传导,通过稳定 PTBP1 mRNA 促进肝母细胞瘤的发展
背景与目标
Circ-CCT2 (hsa_circ_0000418) 是一种源自 CCT2 基因的新型环状 RNA。然而,circ-CCT2的表达及其在肝母细胞瘤中的作用尚不清楚。我们的研究旨在研究 circ-CCT2 在肝母细胞瘤发展中的作用。
方法
收集肝母细胞瘤标本检查circ-CCT2、TAF15和PTBP1的表达。 CCK-8 和集落形成测定用于细胞增殖分析。通过伤口愈合和 Transwell 测定评估迁移和侵袭能力。通过荧光原位杂交、RNA Pull-down 和 RNA 免疫沉淀验证了 circ-CCT2、TAF15 和 PTBP1 之间的相互作用。 SKL2001 用作 Wnt/β-连环蛋白途径的激动剂。建立肝母细胞瘤皮下小鼠模型,用于研究circ-CCT2在体内肝母细胞瘤中的功能。
结果
Circ-CCT2 在肝母细胞瘤中显着上调。 circ-CCT2 的过度表达激活 Wnt/β-catenin 信号传导并促进肝母细胞瘤进展,而 circ-CCT2 的敲低则产生相反的效果。此外,TAF15和PTBP1在肝母细胞瘤组织和细胞中均上调。肝母细胞瘤中TAF15与circ-CCT2、PTBP1的表达呈正相关。此外,circ-CCT2 招募并上调 TAF15 蛋白以稳定 PTBP1 mRNA 并触发肝母细胞瘤中的 Wnt/β-catenin 信号传导。 TAF15 或 PTBP1 的过表达可逆转 circ-CCT2 介导的肝母细胞瘤进展抑制的敲低。 SKL2001 介导的 Wnt/β-catenin 信号传导激活逆转了 circ-CCT2、TAF15 或 PTBP1 沉默的抗肿瘤作用。
结论
Circ-CCT2 通过招募和上调 TAF15 蛋白来稳定 PTBP1 mRNA 并激活 Wnt/β-catenin 信号传导,从而促进肝母细胞瘤进展。我们的研究结果加深了对肝母细胞瘤发病机制的理解并提出了潜在的治疗靶点。